The present study demonstrates the estrogenic effects of fluorotelomer alcohols (FTOHs). In a yeast two-hybrid assay, treatment with 1H,1H,2H,2H-perfluorooctan-1-ol (6:2 FTOH), 1H,1H,2H,2H-perfluoro-decan-1-ol (8:2 FTOH) and 2,2,3,3,4,-4,5,5,6,6,7,7,8,8,9,9,10,10,10-nonadecafluoro-1-decanol (NFDH) showed a dose-dependent interaction between the human estrogen receptor (hER) isoforms hERa a or hERb b ligand-binding domain and coactivator TIF2, whereas there were no estrogenic effects of perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) for these hERs. The estrogenic effects of FTOHs on hERa a were higher than those on hERb b, indicating a differential responsiveness of hERs to FTOHs. The relative ranks of tested chemicals on the estrogenic effects for hERa a and hERb b descended in the order of estradiol-17b bϾ Ͼ Ͼ6:2 FTOHϾ NFDHϾ8:2 FTOH. These results suggest that certain FTOHs including 6:2 FTOH, 8:2 FTOH and NFDH interact with hER isoforms a a and b b in vitro. Further studies are necessary to investigate contamination levels, potential biological effects and the risks of these compounds on human health.Key words human estrogen receptor a; human estrogen receptor b; fluorotelomer alcohols; estrogenic effect Perfluorochemicals (PFCs) such as perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) are widespread contaminants that have been detected in wildlife and humans. 1,2) Various studies have demonstrated the potential maternal and developmental toxicity of these compounds in experimental animals.3) Fluorotelomer alcohols (FTOHs) such as 6:2, 8:2 and 10:2 FTOH are classes of compounds recently identified as potential contaminant sources of PFCs, including PFOA, in the environment. Their presence is particularly noted in the atmospheric environment. 4,5) Limited information is currently available on the toxicological effects and the risks of FTOHs in experimental animals, although these compounds are metabolically converted to PFOA, associated with the induction of hepatic peroxisome proliferation and acyl-CoA oxidase (ACOX) activity.
6)Interestingly, a recent study showed the proliferation-promoting capacity of 6:2 FTOH and 8:2 FTOH with an E-screen assay of MCF-7 cell lines. 7) However, in that study there was no information on the interaction of FTOHs toward human estrogen receptor a (hERa) or b (hERb). To evaluate the potential risks of FTOHs in humans, it is important to investigate estrogenic effects at the molecular level, because PFCs including PFOA, which are degraded from FTOHs, are widespread contaminants that have been detected in human blood samples.2) Therefore, in this study, we investigated the estrogenic effects of FTOHs for the hERa or hERb using a yeast two-hybrid assay.
MATERIALS AND METHODSTest Chemicals 6:2 FTOH (1H,1H,2H,2H-perfluorooctan-1-ol, Alfa Aesar, MA, U.S.A.), 8:2 FTOH (1H,1H,2H,-2H-perfluoro-decan-1-ol, Alfa Aesar), NFDH (2,2,3,3,4,4,-5,5,6,6,7,7,8,8,9,9,10,10,10-nonadecafluoro-1-decanol, Wako Pure Chemical Industries, Ltd., Tokyo, Japan), PFOS (Av...